<p class="p1">Join us for a conversation about the SAGE-217 phase 2 trial, a new agent under investigation for the treatment of major depressive disorder! We talk about phases of trials, intention to treat vs. per-protocol analysis, and what the heck least mean square differences are. Follow us on Instagram and Twitter @Med_Lit_Review, and share your thoughts! 🔥</p>

Join us for a conversation about the SAGE-217 phase 2 trial, a new agent under investigation for the treatment of major depressive disorder! We talk about phases of trials, intention to treat vs. per-protocol analysis, and what the heck least mean square differences are. Follow us on Instagram and Twitter @Med_Lit_Review, and share your thoughts! 🔥

<p>Join us for a conversation about the SAGE-217 phase 2 trial, a new agent under investigation for the treatment of major depressive disorder! We talk about phases of trials, intention to treat vs. per-protocol analysis, and what the heck least mean square differences are. Follow us on Instagram and Twitter @Med_Lit_Review, and share your thoughts! 🔥</p>

Episode 2: SAGE Advice

A med ed podcast where we discuss important publications and recent trials through case-based discussions between friends. Join us as we explore the medical literature - It's gunna be lit.

Share Episode 2: SAGE Advice

Sign up to save your podcasts

Episode 2: SAGE Advice

Episode 2: SAGE Advice